We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current BDX market cap is 24.22M. The company's latest EPS is AUD -0.0201 and P/E is -4.98.
Year End 30 June 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Revenue | 442k | 0 | 275k | 700k | 4.03M |
Operating Income | -697k | 0 | -1.53M | -3.4M | -5.08M |
Net Income | -696k | 0 | -1.53M | -3.39M | -5.06M |
Year End 30 June 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Assets | 820k | 15.32M | 4.13M | 10.59M | 8.37M |
Total Liabilities | 381k | 85k | 526k | 950k | 3.16M |
Total Equity | 439k | 15.23M | 3.61M | 9.64M | 5.21M |
Year End 30 June 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Operating | -662k | N/A | -1.21M | -3.22M | -6.05M |
Investing | -4k | N/A | -4k | -4.03M | 3.64M |
Financing | 805k | N/A | 4.2M | 9.41M | 13k |
Market Cap | 24.22M |
Price to Earnings Ratio | -4.98 |
Price to Sales Ratio | 6.25 |
Price to Cash Ratio | 7.94 |
Price to Book Ratio | 4.84 |
Dividend Yield | - |
Shares Outstanding | 252.29M |
Average Volume (1 week) | 238.19k |
Average Volume (1 Month) | 306.31k |
52 Week Change | 4.35% |
52 Week High | 0.21 |
52 Week Low | 0.07 |
Spread (Intraday) | 0 (1.04%) |
Company Name | BCAL Diagnostics Ltd |
Address |
suite 506, level 5 sydney, new south wales 2000 |
Website | https://www.bcaldiagnostics.com |
Industry | testing laboratories (8734) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions